FDA's Kratom Campaign Turns To Firms Destroying Inventory, Recalling Products
This article was originally published in The Rose Sheet
Executive Summary
FDA announcement that Missouri firm Divinity Products will recall and destroy kratom was part of the agency's latest warning that ingredients derived from the herb are not safe for use in supplements or for therapeutic use to treat symptoms of withdrawal from opioid abuse. FDA doesn't get agreement from the kratom sector about the herb's status as a dietary ingredient as well as its safety profile.
You may also be interested in...
Failed NDIs, FDA's Opioid Concerns Don't Stop Kratom Supplement Sales
Proponents say the herbal ingredient extracted from a plant in the coffee family and available in powders, capsules or pills and beverages has been used in the US since long before the October 1994 grandfather date for ingredients to be eligible for use in supplements without being notified to FDA as new. But FDA wants NDI notifications, and the four submitted so far have been incomplete or did not show safety for intended use in a supplement.
Ion Spectrometer Improves FDA's Import Screening: Health And Wellness Industry News
FDA implementing ion mobility spectrometer devices for faster import screening; Kratom products recalled in Utah in salmonella investigation; ABC names Low Dog first Kronenberg Award winner; and AHPA revises liability insurance primer.
Kratom Suspected In 35-State Salmonella Outbreak: Health And Wellness Industry News
Kratom suspected in 35-state salmonella outbreak; FTC mails refunds for false weight loss ads; Spear at tip of Nutrition 21 sales; and BioCell Collagen halal certified.